JeromeRitzMD
Hematology • Boston, MAHematologic Oncology
Professor of Medicine, Dana-Farber Cancer Institute
Dr. Ritz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
M530, Dana-Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-3465Fax+1 617-632-5167
Summary
- Dr. Jerome Ritz is a hematologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. He is Professor of Medicine at Harvard Medical School. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 45 years. He specializes in hematologic oncology and is experienced in hematologic oncology, hematopoietic stem cell transplantation and cellular therapies. He is currently Executive Director of the Connell and O'Reilly Families Cell Manipulation Core Facility.
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1972 - 1975
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
MA State Medical License 1976 - 2025
CO State Medical License 1975 - 1980
WI State Medical License 1973 - 1979- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2021
- Elected Member The American Society for Clinical Investigation, 1990
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 62 citationsImpaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.Benedetta Rambaldi, Haesook T. Kim, Carol Reynolds, Sharmila Chamling Rai, Yohei Arihara
Blood Advances. 2021-01-26 - 271 citationsThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Tri...Kenneth R. Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T. Hakim, Madan Jagasia
Biology of Blood and Marrow Transplantation. 2017-02-01 - 815 citationsInterleukin-2 and Regulatory T Cells in Graft-versus-Host DiseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T. Kim, Sean McDonough, Bhavjot Bindra
The New England Journal of Medicine. 2011-11-30
Journal Articles
- Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host DiseaseJoseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood
- Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell ResponseIsaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology
Abstracts/Posters
- Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Graft Failure after Haploidentical Hematopoietic Stem Cell TransplantationJerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T CellsJerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024- New Research Offers Hope for Safer and More Effective Blood Stem Cell TransplantsSeptember 4th, 2024
- National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory BoardOctober 25th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
